ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,232.21
0.35%
US Tech 100
17,754.00
0.64%
다우존스 지수
39,533.80
0.37%
Bitcoin
62,983.32
-0.10%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Novelion Therapeutics Inc (NVLN)

  7. Novelion Therapeutics Inc (NVLN) 뉴스

NVLN

Novelion Therapeutics (NVLN)

Novelion Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NVLN
일자시간출처헤드라인심볼기업
2020/03/3105:30Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:NVLNNovelion Therapeutics Inc
2020/02/1406:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/2207:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/2204:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1607:26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1607:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1107:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/1020:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2020/01/0406:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1803:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1306:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1122:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/12/1006:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/2707:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/2220:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/1606:33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:NVLNNovelion Therapeutics Inc
2019/11/0604:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/1706:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0821:10GlobeNewswire Inc.Novelion Therapeutics Announces Nasdaq DelistingNASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0821:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0821:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0419:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0407:21GlobeNewswire Inc.Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matter...NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0406:18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0405:42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0405:40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0306:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVLNNovelion Therapeutics Inc
2019/10/0306:12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/09/2806:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVLNNovelion Therapeutics Inc
2019/09/2805:59Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVLNNovelion Therapeutics Inc
 검색 관련기사 보기:NASDAQ:NVLN

최근 히스토리

NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
CCOM
SILVER
SILVER
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
CCOM
US100
US Tech 100
NYSE
AXP
American Express
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유